Federal Contractor Profile
Ministry Of Defence
$116M obligated·69 awards·3 agencies·14 NAICS
Federal Contracts
Showing award actions 101–144 of 144 funded award actions, most recent first.
- Contracts with positive obligations
- 69
- Funded award actions shown
- 144
- Obligations shown
- $116M
- Awarding agencies
- 3
This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.
Award data as of September 10, 2026. Source: USAspending federal award records.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Aug 24, 2017 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0014 | 541711 | IGF::OT::IGF BASE PERIOD - AD92 | $400K |
| Aug 23, 2017 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA117C0028 | 541712 | CRYSTALCAST TOOLSET IGF::OT::IGF | $1.0M |
| Jul 18, 2017 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0014 | 541711 | IGF::OT::IGF BASE PERIOD - AD92 | $53K |
| Jul 17, 2017 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0020 | 541711 | ANTHRAX DETECTION - BASE IGF::OT::IGF | $70K |
| Jun 28, 2017 | Department of DefenseW6QK ACC-APG NATICK | W911QY17C0067 | 541712 | MARBURG VIRUS MODEL DEVELOPMENT IGF::OT::IGF | $1.0M |
| Jun 27, 2017 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0017 | 541711 | IGF::OT::IGF BASE PERIOD - AD92 | $365K |
| Jun 20, 2017 | Department of Health and Human ServicesNIH NCI | HHSN261201700022A | 541380 | IGF::OT::IGF - LINKAGE OF CLINICAL PRACTICE RESEARCH DATALINK (CPRD) TO THE NATIONAL CANCER DATA REGISTRY (NCDR) DATABASE FOR TWO PROJECTS ASSESSING RELATIONSHIPS BETWEEN HORMONES AND CANCERS | $16K |
| May 23, 2017 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN272201600045C | 541711 | IGF::OT::IGF THIS CONTRACT WAS AWARDED AS A RESULT OF A NOVATION. THE PRIOR CONTRACT, HHSN272201200032C PUBLIC HEALTH ENGLAND, IS NOW THE CURRENT HHSN272201600045C AND THE SUCCESSOR-IN-INTEREST CONTRACTOR IS PORTON BIOPHARMA LIMITED. | $5.6M |
| Apr 28, 2017 | Department of DefenseW6QK ACC-APG NATICK | W911QY17C0067 | 541712 | MARBURG VIRUS MODEL DEVELOPMENT IGF::OT::IGF | $490K |
| Apr 19, 2017 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | HHSF223201400036I | 541990 | IGF::CL,CT::IGF OR IGF::CT,CL::IGF ACCESS TO LONGITUDINAL PATIENT-LEVEL ELECTRONIC MEDICAL RECORD (EMR) DATA. | $434K |
| Apr 3, 2017 | Department of DefenseDEF ADVANCED RESEARCH PROJECTS AGCY | HR001117C0067 | 541711 | IGF::OT::IGF - INTERFERING AND CO-EVOLVING PREVENTION AND THERAPY (INTERCEPT) PROGRAM | $490K |
| Mar 17, 2017 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0014 | 541711 | IGF::OT::IGF BASE PERIOD - AD92 | $300K |
| Mar 16, 2017 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0017 | 541711 | IGF::OT::IGF BASE PERIOD - AD92 | $200K |
| Feb 15, 2017 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0014 | 541711 | IGF::OT::IGF BASE PERIOD - AD92 | $53K |
| Feb 14, 2017 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0020 | 541711 | ANTHRAX DETECTION - BASE IGF::OT::IGF | $515K |
| Feb 13, 2017 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0011 | 541711 | IGF::OT::IGF CORRELATING PRE-SYMPTOMATIC BIOMARKER SIGNATURES FOR SEPSIS WITH BIOLOGICAL WARFARE AGENT (BWA) INFECTION | $310K |
| Feb 6, 2017 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0008 | 541711 | BASE PERIOD | $703K |
| Feb 2, 2017 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0023 | 541711 | DIAGNOSTIC META-ANALYSIS - BASE IGF::OT::IGF | $319K |
| Jan 23, 2017 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0019 | 541711 | BASE PERIOD IGF::OT::IGF | $842K |
| Jan 12, 2017 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN272201600045C | 541711 | IGF::OT::IGF THIS CONTRACT WAS AWARDED AS A RESULT OF A NOVATION. THE PRIOR CONTRACT, HHSN272201200032C PUBLIC HEALTH ENGLAND, IS NOW THE CURRENT HHSN272201600045C AND THE SUCCESSOR-IN-INTEREST CONTRACTOR IS PORTON BIOPHARMA LIMITED. | $814K |
| Dec 6, 2016 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0006 | 541711 | BASE PERIOD | $45K |
| Nov 23, 2016 | Department of Health and Human ServicesNIH NCI | HHSN261201700038P | 519130 | IGF::OT::IGF OTHER FUNCTIONS - CLINICAL PRACTICE RESEARCH DATALINK (CPRD) DATABASE ACCESS. | $183K |
| Nov 16, 2016 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN272201600045C | 541711 | IGF::OT::IGF THIS CONTRACT WAS AWARDED AS A RESULT OF A NOVATION. THE PRIOR CONTRACT, HHSN272201200032C PUBLIC HEALTH ENGLAND, IS NOW THE CURRENT HHSN272201600045C AND THE SUCCESSOR-IN-INTEREST CONTRACTOR IS PORTON BIOPHARMA LIMITED. | $143K |
| Nov 9, 2016 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0011 | 541711 | IGF::OT::IGF CORRELATING PRE-SYMPTOMATIC BIOMARKER SIGNATURES FOR SEPSIS WITH BIOLOGICAL WARFARE AGENT (BWA) INFECTION | $310K |
| Nov 1, 2016 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0020 | 541711 | ANTHRAX DETECTION - BASE IGF::OT::IGF | $150K |
| Oct 27, 2016 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0023 | 541711 | DIAGNOSTIC META-ANALYSIS - BASE IGF::OT::IGF | $319K |
| Sep 30, 2016 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0021 | 541711 | IGF::OT::IGF COUNTER-WMD ANALYSIS CELL (C-WAC) | $182K |
| Sep 22, 2016 | Department of Health and Human ServicesNIH NCI | HHSN261201600778P | 519130 | IGF::OT::IGF OTHER FUNCTIONS. CPRD DATABASE LICENSE | $28K |
| Aug 31, 2016 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0020 | 541711 | ANTHRAX DETECTION - BASE IGF::OT::IGF | $500K |
| Aug 3, 2016 | Department of EnergyNNSA NON-MO CNTRCTNG OPS DIV | DENA0003141 | 531130 | IGF::OT::IGF PATRONUS CAMPAIGN, SERVICE, TO SUPPLY DEPARTMENT OF ENERGY WITH LOGISTICS AND ADMINISTRATIVE PLANNERS FOR THE PATRONUS CAMPAIGN FOR OFFICE OF NUCLEAR WEAPON STOCKPILE. | $400K |
| Jun 23, 2016 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0018 | 541711 | BASE PERIOD - AD92 IGF::OT::IGF | $1.7M |
| Jun 22, 2016 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | HHSF223201400036I | 541990 | IGF::CL,CT::IGF OR IGF::CT,CL::IGF ACCESS TO LONGITUDINAL PATIENT-LEVEL ELECTRONIC MEDICAL RECORD (EMR) DATA. | $434K |
| Jun 22, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO10033002T | 325414 | IGF::OT::IGF FOR OTHER FUNCTIONS | $2.4M |
| May 24, 2016 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0014 | 541711 | IGF::OT::IGF BASE PERIOD - AD92 | $626K |
| Apr 18, 2016 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0011 | 541711 | IGF::OT::IGF CORRELATING PRE-SYMPTOMATIC BIOMARKER SIGNATURES FOR SEPSIS WITH BIOLOGICAL WARFARE AGENT (BWA) INFECTION | $800K |
| Mar 30, 2016 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0001 | 541711 | BASE PERIOD | $328K |
| Mar 10, 2016 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0017 | 541711 | IGF::OT::IGF BASE PERIOD - AD92 | $351K |
| Mar 10, 2016 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0006 | 541711 | BASE PERIOD | $604K |
| Mar 1, 2016 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0008 | 541711 | BASE PERIOD | $500K |
| Feb 24, 2016 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0002 | 541711 | VIRUS LIKE PARTICLES AS A NOVEL PLATFORM FOR DELIVERY OF PROTECTIVE ANTIGENS OF BURKHOLDERIA R&D EFFORT. | $402K |
| Jan 7, 2016 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0007 | 541711 | BASE PERIOD | $56K |
| Dec 10, 2015 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0017 | 541711 | IGF::OT::IGF BASE PERIOD - AD92 | $200K |
| Dec 3, 2015 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0011 | 541711 | IGF::OT::IGF CORRELATING PRE-SYMPTOMATIC BIOMARKER SIGNATURES FOR SEPSIS WITH BIOLOGICAL WARFARE AGENT (BWA) INFECTION | $994K |
| Oct 1, 2015 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA111C0039 | 541711 | DEVELOPMENT OF COMMON MARMOSET MODELS FOR CATEGORY A/B PATHOGENS AND PRODUCT EVALUATION IN MARMOSETS R&D EFFORT. | $231K |
Get Alerted Before Ministry Of Defence's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start for free